Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.32B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$2.19B |
| 3 |
Apple
AAPL
|
+$2.17B |
| 4 |
NVIDIA
NVDA
|
+$2.12B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$563M |
| 2 |
Jefferies Financial Group
JEF
|
+$510M |
| 3 |
SPDR Gold Trust
GLD
|
+$313M |
| 4 |
S&P Global
SPGI
|
+$286M |
| 5 |
CrowdStrike
CRWD
|
+$196M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.69% |
| 2 | Consumer Discretionary | 7.38% |
| 3 | Financials | 7.04% |
| 4 | Healthcare | 5.93% |
| 5 | Communication Services | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Sterling Infrastructure
STRL
$17.8B
| $3.32M | ﹤0.01% |
29,301
-6,831
| -19% | -$962K |
|
2227
CALL
Arbor Realty Trust
ABR
$921M
| $3.31M | ﹤0.01% |
281,900
-41,000
| -13% | -$531K |
|
2228
LivaNova
LIVN
$4.45B
| $3.31M | ﹤0.01% |
84,251
+28,504
| +51% | +$1.28M |
|
2229
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.5B
| $3.31M | ﹤0.01% |
141,219
-11,360
| -7% | -$268K |
|
2230
Albemarle Corp Depositary Shares
ALB.PRA
$2.41B
| $3.3M | ﹤0.01% |
92,652
+38,224
| +70% | +$1.51M |
|
2231
Ascendis Pharma A/S
ASND
$16.5B
| $3.3M | ﹤0.01% |
21,164
+116
| +0.6% | +$16.6K |
|
2232
Schwab US Broad Market ETF
SCHB
$43B
| $3.3M | ﹤0.01% |
153,142
+6,016
| +4% | +$137K |
|
2233
Minerals Technologies
MTX
$2.25B
| $3.29M | ﹤0.01% |
51,769
+4,585
| +10% | +$327K |
|
2234
iShares Short Maturity Bond ETF
NEAR
$4.83B
| $3.29M | ﹤0.01% |
64,659
+2,540
| +4% | +$129K |
|
2235
Gold Fields
GFI
$30B
| $3.29M | ﹤0.01% |
148,715
-14,150
| -9% | -$259K |
|
2236
Tetra Tech
TTEK
$8.42B
| $3.28M | ﹤0.01% |
112,071
-24,634
| -18% | -$827K |
|
2237
Wipro
WIT
$19.3B
| $3.28M | ﹤0.01% |
1,071,100
-134,875
| -11% | -$460K |
|
2238
NorthWestern Energy
NWE
$4.29B
| $3.28M | ﹤0.01% |
56,603
-8,482
| -13% | -$461K |
|
2239
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $3.27M | ﹤0.01% |
65,595
-3,585
| -5% | -$176K |
|
2240
Ingredion
INGR
$6.33B
| $3.27M | ﹤0.01% |
24,168
+1,321
| +6% | +$174K |
|
2241
SoundHound AI
SOUN
$2.68B
| $3.27M | ﹤0.01% |
402,199
-5,299
| -1% | -$66.1K |
|
2242
Smith & Nephew
SNN
$13.6B
| $3.26M | ﹤0.01% |
114,820
-3,999
| -3% | -$107K |
|
2243
Primerica
PRI
$10.1B
| $3.25M | ﹤0.01% |
11,426
+1,669
| +17% | +$476K |
|
2244
Transmedics
TMDX
$2.63B
| $3.25M | ﹤0.01% |
48,287
+2,486
| +5% | +$171K |
|
2245
Healthcare Realty
HR
$7.46B
| $3.25M | ﹤0.01% |
192,120
+21,965
| +13% | +$365K |
|
|
EXAS
2246
PUT
DELISTED
Exact Sciences
EXAS
| $3.25M | ﹤0.01% |
+75,000
| New | +$3.8M |
|
2247
CALL
Krystal Biotech
KRYS
$10.8B
| $3.25M | ﹤0.01% |
18,000
-2,000
| -10% | -$336K |
|
|
2248
PUT
Krystal Biotech
KRYS
$10.8B
| $3.25M | ﹤0.01% |
18,000
-2,000
| -10% | -$336K |
|
|
MPT
2249
PUT
Medical Properties Trust
MPT
$2.81B
| $3.24M | ﹤0.01% |
538,100
-2,216,300
| -80% | -$11.2M |
|
2250
PUT
Moderna
MRNA
$23B
| $3.23M | ﹤0.01% |
+113,800
| New | +$4.04M |
|
Similar funds
Citigroup's Q1 2025 Portfolio in Review
As of Q1 2025, Citigroup held 6,124 positions worth $196B, up 16% from $169B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup deployed $38.1B of net new capital in Q1 2025, opening 294 new positions and adding to 2,193 existing holdings. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares China Large-Cap ETF, an estimated $563M trimmed.
- Citigroup's largest Q1 2025 buy was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
- Citigroup added most to Microsoft in Q1 2025, an estimated $2.32B increase.
- Citigroup's biggest Q1 2025 reduction was iShares China Large-Cap ETF, cutting an estimated $563M.
- Citigroup fully exited Retail Opportunity Investments Corp. in Q1 2025, selling an estimated $46.9M.
- Citigroup's ten largest holdings make up 24% of its $196B portfolio in Q1 2025.
- Citigroup opened 294 new positions and closed 585 in Q1 2025.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $196B.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.